Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Platform Trial Evaluating the Role of Interventions to Prevent Infection in Patients With Acquired Hypogammaglobulinemia Secondary to Haematological Malignancies - RATIONAL-PT (Core)

NCT07202052 is registered in ClinicalTrials.gov with Monash University as lead sponsor.

NCT NCT07202052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07202052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Platform Trial Evaluating the Role of Interventions to Prevent Infection in Patients With Acquired Hypogammaglobulinemia Secondary to Haematological Malignancies - RATIONAL-PT (Core)
Lead sponsor
Monash University
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 6, 2025
Completion date
March 31, 2027
Enrollment
900 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloma, non-hodgkin's lymphoma